Trump Administration Defers on Mifepristone Lawsuit | JQJO

The Trump administration surprisingly moved to dismiss a lawsuit targeting the abortion pill mifepristone, a move that puzzles experts. While seemingly a win for abortion access, it allows the administration to avoid directly confronting the issue and potentially restrict access later through the FDA. The lawsuit, initially filed by anti-abortion doctors and taken over by Republican attorneys general, aimed to reverse FDA regulations expanding mifepristone access. The administration's argument centers on the lack of standing for the current plaintiffs, leaving open the possibility of future FDA action to limit access, despite the drug's safety record.